| Accession |
PRJCA022398 |
| Title |
CS1001-304 PD-L1 IHC Data |
| Relevance |
Medical |
| Data types |
PD-L1 IHC data
|
| Organisms |
Homo sapiens
|
| Description |
Phase III Study to Investigate the Efficacy and Safety of CS1001 or Placebo in Combination with FP as First-Line Therapy in Subjects with Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma |
| Sample scope |
Multiisolate |
| Release date |
2024-01-31 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| CStone
|
|
NA
|
|
|
|
| Submitter |
Li
Jin (lijin@csco.org.cn)
|
| Organization |
Shanghai East Hospital |
| Submission date |
2023-12-21 |
